GSP Crop Science IPO Details
GSP Crop Science IPO Summary
GSP Crop Science IPO opens for subscription on 16 Mar 2026 and closes on 18 Mar 2026.The IPO will be listed on NSE, BSE with the tentative listing date set for 23 Mar 2026.
GSP Crop Science IPO price band has been fixed at ₹304 – ₹320 per share. The face value is ₹10 per share with a lot size of 46.
GSP Crop Science IPO total issue size comprises 1,25,00,000 shares (aggregating up to ₹400.00 Cr). This includes a fresh issue of 75,00,000 shares (aggregating up to ₹240.00 Cr). Offer for Sale consists of 50,00,000 shares (aggregating up to ₹160.00 Cr). Pre-issue shareholding stands at 3,90,18,750, which will increase to 4,65,18,750 post-issue.
GSP Crop Science IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.
GSP Crop Science IPO Lot Size :Retail Minimum is 1 lot (46 shares) amounting to ₹14,720. Retail Maximum is 13 lots (598 shares) amounting to ₹191,360. SHNI Minimum is 14 lots (644 shares) amounting to ₹206,080. SHNI Maximum is 67 lots (3,082 shares) amounting to ₹986,240. BHNI Minimum is 68 lots (3,128 shares) amounting to ₹1,000,960.
GSP Crop Science IPO Details
GSP Crop Science IPO Subscription
GSP Crop Science IPO Application Wise Breakup (Approx)
GSP Crop Science IPO Dates
- 16 Mar 2026Opening dateOpen
- 18 Mar 2026Closing dateClose
- 19 Mar 2026Allotment Date Allotment
- 20 Mar 2026Initiation of RefundsRefund
- 20 Mar 2026Credit of SharesCredit
- 23 Mar 2026Listing dateListing
GSP Crop Science IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 46 | ₹14,720 |
| Retail Maximum | 13 | 598 | ₹191,360 |
| SHNI Minimum | 14 | 644 | ₹206,080 |
| SHNI Maximum | 67 | 3082 | ₹986,240 |
| BHNI Minimum | 68 | 3128 | ₹1,000,960 |
GSP Crop Science IPO Reservation
Promoter Holding
Documents
GSP Crop Science IPO Valuations
GSP Crop Science Financial Information
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 1,491.69 | 1,228.50 | 980.34 | 1,132.13 |
| Total Income | 847.61 | 1,301.06 | 1,158.23 | 1,206.05 |
| Profit After Tax | 81.07 | 81.42 | 55.54 | 17.57 |
| EBITDA | 138.86 | 164.03 | 130.41 | 81.28 |
| NET Worth | 529.85 | 450.03 | 370.46 | 363.47 |
| Reserves and Surplus | 490.84 | 411.02 | 344.46 | 336.00 |
| Total Borrowing | 321.13 | 295.60 | 235.44 | 324.26 |
| Amount in ₹ Crore | ||||
About GSP Crop Science IPO
GSP Crop Science Limited, incorporated in 1985, is an agrochemical company engaged in the manufacturing of insecticides, herbicides, fungicides, and plant growth regulators. The company focuses on providing crop protection solutions that help farmers enhance agricultural productivity and effectively manage pests, weeds, and crop diseases.
The company develops and manufactures agrochemical products in the form of Formulations and Technicals. Formulations consist of active ingredients combined with additives and are designed for direct application, while Technicals represent concentrated active ingredients used in the production of crop protection products.
GSP Crop Science Limited offers a diversified portfolio of in-house manufactured agrochemicals and provides comprehensive crop protection solutions through the development, manufacturing, supply, and distribution of Formulations and Technicals to meet customer requirements.
The company serves customers across a wide domestic and international network. In India, it has served customers across 20 states during the six months ended September 30, 2025, and during Fiscal years 2025, 2024, and 2023. Internationally, the company operates in 37 countries including the United States of America, Uruguay, Brazil, Vietnam, Singapore, the United Arab Emirates, and Australia, with presence across regions such as Latin America, Asia Pacific (excluding India), North America, and other global markets.
As of September 30, 2025, the company had received 524 registrations across Formulations and Technicals for its agrochemical products. The company’s ongoing research and development initiatives have resulted in the grant of 102 patents, with an additional 108 patent applications under process as of March 10, 2026.
The company continues to invest in research and development to enhance and expand its product portfolio. It operates dedicated R&D facilities in Kathwada and Odhav, which support product testing, commercialization, and the development of complex chemistries for the agrochemical market.
Business Operations
Formulations: As of September 30, 2025, the company held 395 registrations for formulations consisting of active ingredients and additives, available in both solid and liquid forms. These products are marketed under the company’s brands or through licensing arrangements.
Technicals: As of September 30, 2025, the company held 129 registrations for technical products. Technicals are concentrated active ingredients that are processed with other components to manufacture crop protection products such as insecticides, herbicides, and fungicides.
As of September 30, 2025, GSP Crop Science Limited had a total workforce of 1,221 permanent employees.
Strength Of GSP Crop Science IPO
- Research-driven agrochemical company with over four decades of industry experience.
- Diversified product portfolio including insecticides, herbicides, fungicides and plant growth regulators.
- Integrated business model with both technical and formulation segments.
- Strong focus on research and development supported by product registrations and patents.
- Established manufacturing footprint with multiple production facilities in India.
Risk Of GSP Crop Science IPO
- The company requires certain approvals and licenses, including certain registrations from the Central Insecticides Board and Registration Committee ("CIBRC") for its products. Regulations governing the production, sale, and use of agrochemicals have become increasingly stringent. Any failures to successfully obtain such registrations or renew or maintain the company's statutory and regulatory permits and approvals required to operate its business and manufacturing facilities would adversely affect the company's operations, results of operations and financial condition.
- The company is subject to stringent technical specifications and quality requirements in relation to the company's Technicals and Formulations. The company's failures to comply with the quality standards and technical specifications may lead to loss of business from such customers and could negatively impact its reputation, which would have an adverse impact on the company's business prospects and results of operations.
- The company is requireds to comply with the applicable regulations of the international geographies where the company undertakes business as well as obtain registrations from foreign governmental authorities through its customers/or directly from foreign regulatory authorities to enable sale of the company's products in such international jurisdictions. Further, the company's International Business is subject to regulatory risks that could adversely affect its business and results of operations.
- The company's cost of materials consumed constituted a majority of the total expenses incurred in the six months ended September 30, 2025, and Fiscals 2025, 2024, and 2023. Any further increase in the company's costs of materials consumed or the company's inability to reasonably offset its costs with the prices of the company's products may have an adverse impact on the company's profitability.
- The company depends on a few suppliers for supply of raw materials. Any failures to procure such raw materials from these suppliers may have an adverse impact on the company's manufacturing operations and results of operations.
- The company is dependents on China for imports of the company's raw materials, with imports of raw materials from China constituting 42.08%, 37.99%, 35.28%, and 31.85% of its purchases for continuing operations in the six months ended September 30, 2025, and Fiscals 2025, 2024, and 2023, respectively. Any interruption in imports, specifically from China, may have an adverse impact on the company's manufacturing operations and results of operations.
- The company derives 57.37%, 62.03%, 60.81%, and 58.78% of the company's revenue from continuing operations for the six months ended September 30, 2025, and Fiscals 2025, 2024, and 2023, respectively from its customers situated in Gujarat, Maharashtra, Andhra Pradesh, Rajasthan and Karnataka. Any instability in the business or financial performance of the company's customers situated in these states could materially affect its business, financial condition, and results of operations.
- The company typicallys does not enter into long-term agreements with its customers. Any inability to retain the company's customers or find replacement customers for its products may have a material adverse impact on the company's profitability, financial condition and results of operations.
- The company is dependents on the company's distribution network for the distribution of Formulations in the company's B-to-C Domestic Business. Any inability to expand or effectively manage or any disruption in the company's distribution network will adversely affect its business and results of operations.
- The company's business is sensitive to seasonal vagaries and adverse weather conditions which affect the agrochemical industry. Seasonal variations and unfavourable local and global weather patterns may have an adverse effect on the company's business, results of operations and financial condition.
Objectives GSP Crop Science IPO
1. Repayment or pre-repayment of all or a portion of certain outstanding borrowings availed by the Company
2. General Corporate Purpose
Company Contact Details
GSP Crop Science Ltd.
404, Lalita Complex, Rasala Road,
Mithakhali Six Road,
Navrangpura,
Ahmedabad, Gujarat, 380009
Phone: +91 79 61915165
Email: cs@gspcrop.com
Website: http://www.gspcrop.in/
Registrar Contact Details
GSP Crop Science FAQs
The GSP Crop Science IPO is a MAINBOARD public issue comprising 12500000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹400.00 Cr. The issue price has been fixed at ₹320 per equity share, and the minimum application size is 46 shares.
The IPO opens for subscription on 16 Mar 2026, and closes on 18 Mar 2026.
MUFG Intime India Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at ₹0 (0%).
Quick Links
Comments
